Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.71 Million EUR | -10.44% |
| 2022 | 3.03 Million EUR | -12.32% |
| 2021 | 3.46 Million EUR | 291.4% |
| 2020 | 884 Thousand EUR | 63865.27% |
| 2019 | 1382.00 EUR | -39.01% |
| 2018 | 2266.00 EUR | 105.07% |
| 2017 | 1105.00 EUR | 8.02% |
| 2016 | 1023.00 EUR | 58.11% |
| 2015 | 647.00 EUR | -99.98% |
| 2014 | 3.3 Million EUR | 214.16% |
| 2013 | 1.05 Million EUR | 151.5% |
| 2012 | 418.64 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.37 Million EUR | 0.0% |
| 2023 FY | 2.71 Million EUR | -10.44% |
| 2023 Q4 | 2.71 Million EUR | 0.0% |
| 2023 Q2 | 2.9 Million EUR | 0.0% |
| 2022 Q2 | 3.39 Million EUR | 0.0% |
| 2022 FY | 3.03 Million EUR | -12.32% |
| 2022 Q4 | 3.03 Million EUR | 0.0% |
| 2021 FY | 3.46 Million EUR | 291.4% |
| 2021 Q2 | 3 Million EUR | 0.0% |
| 2021 Q4 | 3 Million EUR | 0.0% |
| 2020 Q4 | 1869.00 EUR | 0.0% |
| 2020 FY | 884 Thousand EUR | 63865.27% |
| 2020 Q2 | 2.35 Million EUR | 0.0% |
| 2019 FY | 1382.00 EUR | -39.01% |
| 2019 Q2 | 1132.00 EUR | 0.0% |
| 2019 Q4 | 1382.00 EUR | 0.0% |
| 2018 Q4 | 2266.00 EUR | 0.0% |
| 2018 FY | 2266.00 EUR | 105.07% |
| 2018 Q2 | 1249.00 EUR | 0.0% |
| 2017 Q2 | 927.00 EUR | 0.0% |
| 2017 FY | 1105.00 EUR | 8.02% |
| 2017 Q4 | 1105.00 EUR | 0.0% |
| 2016 Q2 | 824.00 EUR | 0.0% |
| 2016 FY | 1023.00 EUR | 58.11% |
| 2016 Q4 | 1023.00 EUR | 0.0% |
| 2015 Q4 | 647.00 EUR | 0.0% |
| 2015 Q2 | 819.00 EUR | 0.0% |
| 2015 FY | 647.00 EUR | -99.98% |
| 2014 Q4 | 3.3 Million EUR | 0.0% |
| 2014 Q2 | 187.26 Thousand EUR | 0.0% |
| 2014 FY | 3.3 Million EUR | 214.16% |
| 2013 FY | 1.05 Million EUR | 151.5% |
| 2013 Q4 | 1.05 Million EUR | 0.0% |
| 2012 FY | 418.64 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ABIONYX Pharma SA | 3.39 Million EUR | 19.857% |
| ABIVAX Société Anonyme | 55.46 Million EUR | 95.102% |
| Adocia SA | 13.08 Million EUR | 79.242% |
| Aelis Farma SA | 4.03 Million EUR | 32.718% |
| Biophytis S.A. | 8.27 Million EUR | 67.148% |
| Advicenne S.A. | 17.42 Million EUR | 84.408% |
| genOway Société anonyme | 7.23 Million EUR | 62.44% |
| IntegraGen SA | 1.12 Million EUR | -141.554% |
| Medesis Pharma S.A. | 1.2 Million EUR | -126.403% |
| Neovacs S.A. | 650 Thousand EUR | -317.975% |
| NFL Biosciences SA | 62.17 Thousand EUR | -4269.735% |
| Plant Advanced Technologies SA | 4.35 Million EUR | 37.637% |
| Sensorion SA | 2.86 Million EUR | 5.297% |
| Theranexus Société Anonyme | 3.64 Million EUR | 25.423% |
| TME Pharma N.V. | 1.16 Million EUR | -133.005% |
| Valbiotis SA | 6.87 Million EUR | 60.5% |
| TheraVet SA | 1.15 Million EUR | -134.237% |
| Valerio Therapeutics Société anonyme | 8.99 Million EUR | 69.806% |
| argenx SE | 18.1 Million EUR | 84.994% |
| BioSenic S.A. | 28.16 Million EUR | 90.352% |
| Celyad Oncology SA | 902 Thousand EUR | -201.202% |
| DBV Technologies S.A. | 13.01 Million USD | 79.131% |
| Galapagos NV | 9.59 Million EUR | 71.688% |
| Genfit S.A. | 70.17 Million EUR | 96.129% |
| GeNeuro SA | 7.73 Million EUR | 64.889% |
| Hyloris Pharmaceuticals SA | 5.29 Million EUR | 48.681% |
| Innate Pharma S.A. | 39.89 Million EUR | 93.19% |
| Inventiva S.A. | 37.4 Million EUR | 92.737% |
| MaaT Pharma SA | 14.07 Million EUR | 80.697% |
| MedinCell S.A. | 58.96 Million EUR | 95.392% |
| Nanobiotix S.A. | 50.56 Million EUR | 94.627% |
| Onward Medical N.V. | 16.87 Million EUR | 83.899% |
| Oryzon Genomics S.A. | 13.68 Million EUR | 80.151% |
| OSE Immunotherapeutics SA | 45.8 Million EUR | 94.068% |
| Oxurion NV | 12.33 Million EUR | 77.973% |
| Pharming Group N.V. | 155.29 Million EUR | 98.251% |
| Poxel S.A. | 46.9 Million EUR | 94.207% |
| GenSight Biologics S.A. | 18.42 Million EUR | 85.257% |
| Transgene SA | 1.25 Million EUR | -116.137% |
| Financière de Tubize SA | 79.2 Million EUR | 96.57% |
| UCB SA | 3.03 Billion EUR | 99.911% |
| Valneva SE | 208.81 Million EUR | 98.699% |
| Vivoryon Therapeutics N.V. | 38 Thousand EUR | -7049.576% |